Methotrexate therapy in juvenile rheumat
β
H. Truckenbrodt; R. HΓ€fner
π
Article
π
1986
π
John Wiley and Sons
π
English
β 614 KB
Nineteen selected patients with severe, mostly systemic onset, juvenile rheumatoid arthritis were treated with methotrexate (MTX) for an average of 10.5 months. Twelve patients showed statistically significant improvement, as measured by the number of affected, swollen, tender, and functionally impa